Proteomic profiles in hyperandrogenic syndromes

Journal of Endocrinological Investigation

Volumn 33, Issue 3, 2010, Pages 156-164

  Misiti, S ^a,b   Stigliano, A ^a,b   Borro, M ^a   Gentile, G ^a   Michienzi, S ^a,b   Cerquetti, L ^a,b   Bucci, B ^b   Argese, N ^a,b   Brunetti, E ^b   Simmaco, M ^a   Toscano, V ^a,b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b FATEBENEFRATELLI HOSPITAL   (Italy)

Author keywords

Congenital adrenal hyperplasia; Polycystic ovary syndrome; Proteomics; T lymphocytes

Indexed keywords

ACNE; ADULT; ANOVULATION; ARTICLE; BIOSENSOR; CLINICAL ARTICLE; CLINICAL FEATURE; CONGENITAL ADRENAL HYPERPLASIA; CONTROLLED STUDY; FEMALE; HIRSUTISM; HUMAN; HUMAN CELL; HYPERANDROGENISM; OVARY POLYCYSTIC DISEASE; PATHOPHYSIOLOGY; PERIPHERAL LYMPHOCYTE; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEOMICS; SIGNAL TRANSDUCTION; STEROID 21 MONOOXYGENASE DEFICIENCY; T LYMPHOCYTE; TWO DIMENSIONAL GEL ELECTROPHORESIS;

ADOLESCENT; ADRENAL HYPERPLASIA, CONGENITAL; ADULT; ANDROSTENEDIONE; DEHYDROEPIANDROSTERONE SULFATE; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; ESTRADIOL; FEMALE; FOLLICLE STIMULATING HORMONE; HUMANS; HYDROCORTISONE; HYDROXYPROGESTERONES; HYPERANDROGENISM; LUTEINIZING HORMONE; MASS SPECTROMETRY; POLYCYSTIC OVARY SYNDROME; PROLACTIN; PROTEOMICS; SEX HORMONE-BINDING GLOBULIN; TESTOSTERONE; YOUNG ADULT;

EID: 77952850892     PISSN: 03914097     EISSN: 17208386     Source Type: Journal    
DOI: 10.1007/BF03346575     Document Type: Article

References (40)

1. Azziz R, Carmina E, and Sawaya ME. Idiopathic hirsutism. Endocrine Review 2000, 21: 347-362
2. Norman RJ, Dewailly D, Legro RS, Hickey TE. Polycystic ovary syndrome. Lancet 2007, 25: 685-697
3. Kuttenn F, Couillin P, Girard F, et al. Late-onset adrenal hyperplasia in hirsutism. N Engl J Med 1985, 313: 224-231 (Pubitemid 15068638)
4. Riepe FG, Sippell WG. Recent advances in diagnosis, treatment, and outcome of congenita adrenal hyperplasia due to 21-hydroxylase deficiency. Rev Endocr Metab Disord 2007, 8: 349-363
5. Speiser PW, White PC. Congenital adrenal hyperplasia. N Engl J Med 2003, 349: 776-788
6. Fratantonio E, Vicari E, Pafumi C, Calogero AE. Genetics of polycystic ovarian syndrome. Reprod Biomed Online 2005, 10: 713-720 (Pubitemid 40796936)
7. Sahin Y, Kelestimur F. The frequency of late-onset 21-hydroxylase and 11-hydroxylase deficiency in women with polycystic ovary syndrome. Eur J Endocrinol 1997, 137: 670-674 (Pubitemid 28005263)
8. Gladkevich A, Kauffman HF, Korf J. Lymphocytes as a neuronal probe: potential for studying psychiatric disorders. Prog Neuropsychopharmacol Biol Psychiatry 2004, 28: 559-576 (Pubitemid 38490769)
9. Hatch R, Rosenfield RL, Kim MH, Tredway D. Hirsutism: implications, ethiology, and management. Am J Obstet Gynecol 1981, 140: 815-830
10. Ehrmann DA, Barnes RB, Rosenfield RL. Polycystic ovary syndrome as a form of functional ovarian hyperandrogenism due to dysregulation of androgen secretion. Endocr Rev 1995, 16: 322-353
11. Schmidt NA, Borburg HJ, Penders TJ, Wejcamp CW. Steroid profiling - an update. Clin Chem 1985, 31: 637-639
12. Wilson RC, Wei JQ, Cheng KC, Mercado AB, New MI. Rapid deoxyribonucleic acid analysis by allele-specific polimerase chain reaction for detection of mutations in the steroid 21-hydroxylase gene. The Jour 1995, 80: 1635-1640
13. Shevchenko A, WiIm M, Vorm O, Mann M. Mass spectrometric sequencing of proteins silver-stained Polyacrylamide gels. Anal Chem 1996, 68: 850-858 (Pubitemid 26101214)
14. Huang TY, DerMardirossian C, Bokoch GM. Cofilin phosphatases and regulation of actin dynamics. Curr Opin Cell Biol 2006, 18: 26-31.
15. Zigmond SH. Beginning and ending an actin filament: control at the barbed end. Curr Top Dev Biol 2004, 63: 145-188
16. Hall A. Rho GTPases and the control of cell behaviour. Biochem Soc Trans 2005, 33: 891-895
17. Miletic AV, Swat M, Fujikawa K, Swat W. Cytoskeletal remodelling in lymphocyte activation. Curr Opin Immunol 2003, 15: 261-268
18. Pancholi V. Multifunctional alpha-enolase: its role in diseases. Cell Mol Life Sci 2001, 58: 902-920 (Pubitemid 32652817)
19. Rhee SG, Chae HZ, Kim K. Peroxiredoxins: a historical overview and speculative preview of novel mechanisms and emerging concepts in cell signalling. Free Radic Biol Med 2005, 38: 1543-1552 (Pubitemid 40726061)
20. Liaudet-Coopman E, Beaujouin M, Derocq D, et al. Cathepsin D: newly discovered functions of a long-standing aspartic protease in cancer and apoptosis. Cancer Lett 2006, 237: 167-179 (Pubitemid 43777078)
21. Yeung KC, Rose DW, Dhillon AS, et al. Raf kinase inhibitor protein interacts with NF-kappaB-inducing kinase and TAKI and inhibits NF-kappaB activation. Mol Cell Biol 2001, 21: 7207-7217
22. Loupatty FJ, van der Steen A, Ijlst L, et al. Clinical, biochemical, and molecular findings in three patients with 3-hydroxyisobutyric aciduria. Mol Genet Metab 2006, 87: 243-248 (Pubitemid 43325039)
23. Wilkinson B, Gilbert HF. Protein disulfide isomerase. Biochim Biophys Acta 2004, 1699: 35-44.
24. Miller AF. Superoxide dismutase: active sites that save, but a protein that kills. Curr Opin Chem Biol 2004, 8: 162-168
25. Ohkawa R, Hirowatari Y, Nakamura K, et al. Platelet release of beta-thromboglobulin and platelet factor 4 and serotonin in plasma samples. Clin Biochem 2005, 38: 1023-1026 (Pubitemid 41606799)
26. Padmanabhan B, Kuzuhara T, Adachi N, Horikoshi M. The crystal structure of CCG1/TAF(II)250-interacting factor B (CIB). J Biol Chem 2004, 279: 9615-9624 (Pubitemid 38296030)
27. Scandalios JG. Oxidative stress: molecular perception and trasduction of signals triggering antioxidant gene defences. Brazilian Journal of Medical and Biological Reserce 2005, 38: 995-1014.
28. Jäger S, Groll M, Huber R, Wolf DH, Heinemeyer W. Proteasome beta-type subunits: unequal roles of propeptides in core particle maturation and a hierarchy of active site function. J Mol Biol 1999, 291: 997-1013. (Pubitemid 29403626)
29. Pan Z, Wang J, Yin X, et al. The function study on the interaction between Grb2 and AMPK. Mol Cell Biochem, 307: 121-127
30. Hanash S. Disease proteomics. Nature 2003, 422: 226-232
31. Samy TS, Knöferl MW, Zheng R, Schwache MG, Bland KI, Chaudry IH. Divergent immune responses in male and female mice after trauma-hemorrhage: dimorphic alterations in T lymphocyte steroidogenic enzyme activities. Endocrine 2001, 142: 3519-3529 (Pubitemid 32681760)
32. Utz PJ. Protein arrays for studyng blood cells and their secreted products. Immunol Rev 2005, 204: 264-282
33. Chen DS, Davis MM. Molecular and functional analysis using live cell microarrays. Curr Opin Chem Biol 2006, 10: 28-34.
34. Hughes C, Elgasim M, Layfield R, Atiomo W. Genomic and post-genomic approaches to polycistic ovary syndrome-progress so far: Mini review. Hum Reprod 2006, 21: 2766-2775
35. Anderson NL, Anderson NG. The human plasma proteome: history, character, and diagnostic prospects. Mol Cell Proteomics 2002, 1: 845-867
36. rd. Molecular abnormalities in oocytes from women with polycystic ovary syndrome revealed by microarray analysis. J Clin Endocrinol Metab 2007, 92: 705-713 (Pubitemid 46255318)
37. Ma X, Fan L, Meng Y, et al. Proteomic analysis of human ovaries from normal and polycystic ovarian syndrome. Mol Hum Reprod 2007, 13: 527-535 (Pubitemid 47241906)
38. Boden G, Duan X, Homko C, et al. Increase in endoplasmic reticulum stress-related proteins and genes in adipose tissue of obese, insulin-resistant individuals. Diabetes 2008, 57: 2438-2444
39. Kusçu NK, Var A. Oxidative stress but not endothelial dysfunction exists in non-obese, young group of patients with polycystic ovary syndrome. Acta Obstet Gynecol Scand 2009, 88: 612-617
40. Barati MT, Merchant ML, Kain AB, Jevans AW, McLeish KR, Klein JB. Proteomic analysis defines altered cellular redox pathways and advanced glycation end-product metabolism in glomeruli of db/db diabetic mice. Am J Physiol Renal Physiol 2007, 293: 1157-1165